Final ID: WP319
Jha Prabhash, Kasai Taku, Vromman Amelie, Holden Rachel, Libby Peter, Tabas Ira, Singh Sasha, Aikawa Elena, Aikawa Masanori, Lupieri Adrien, Sonawane Abhijeet, Le Thanh-dat, Becker-greene Dakota, Chelvanambi Sarvesh, Turner Mandy, Nakamura Yuto, Passos Livia
A transformative LDL cholesterol–lowering in vivo CRISPR gene editing medicine that functionally upregulates LDLR in mice and non-human primatesNewmark Judith, Raghav Jimit, Jaskolka Michael, Diner Benjamin, Soman Vikram, Jinadasa Tushare, Apte Ameya, Wu Meng, Bottega Steve, Thakkar Mansi, Agosto Luis, Wrighton Paul, Majithia Deep, Jambard Shreya, Jansson-fritzberg Linnea, Jones Mark, Fletcher Jillian, Weiss Mckenzie, Kaye Emily, Steward Briana, Bochicchio James, Pietrasiewicz Stephen, Iovino Salvatore, Marco Rubio Eugenio, Trong Phan Huu, Chander Nisha, Kazemian Mohammadreza, Lam Kieu, Reid Steve, Dinsmore Michael, Teslovich Tanya, Xie Jenny, Gupta Anshul, Amin Parth, Burkly Linda, Thompson Morgan, Rizal Salu, Bilodeau Maxime, Dong Ruhong, Zhen Wei
We encourage you to enter the discussion by posting your comments and questions below.
Presenters will be notified of your post so that they can respond as appropriate.
This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.
You have to be authorized to post a comment. Please, Login or Signup.